Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-06-11

Clinical Trial Update: Post-Operative Pain Control Using Direct Continuous Bupivacaine Infusion After Pelvic Organ Prolapse Repair [Phase 2, Phase 3]

View source ↗

Summary

The document reports a Phase 2/3 clinical trial evaluating direct continuous bupivacaine infusion for postoperative pain control after pelvic organ prolapse rep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: St. Luke's Hospital, Kansas City, Missouri | Conditions: Post-Operative Pain, Pelvic Organ Prolapse | Phase 2, Phase 3 | Status: UNKNOWN